Notes
derived from Greek 2002 official pricelist
Reference
Tsaganos T, et al. CLARITHROMYCIN LEADS TO LONG-TERM SURVIVAL AND COST BENEFIT IN VENTILATOR-ASSOCIATED PNEUMONIA AND SEPSIS. Antimicrobial Agents and Chemotherapy : 4 Apr 2016. Available from: URL: http://doi.org/10.1128/AAC.02974-15
Rights and permissions
About this article
Cite this article
Clarithromycin reduces hospital costs in VAP and sepsis. PharmacoEcon Outcomes News 751, 10 (2016). https://doi.org/10.1007/s40274-016-2970-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-2970-z